Fecal Incontinence Clinical Trial
Official title:
Anal Incontinence After Delivery. Secondary Prevention With Caesarean Section.
Anal incontinence is frequent and treatment is difficult. One of the most important reasons is traumatic delivery. 10 % of women develop anal incontinence after first delivery. This incidence is higher after second vaginal delivery, particularly if the first delivery caused break in the anal sphincter. One possibility to avoid anal incontinence is the caesarean section. So, do the investigators have to recommend caesarean section for second delivery if the first was traumatic? But caesarean section had a morbidity. Actually, the choice between the delivery modalities is very subjective.
Anal incontinence is frequent and treatment is difficult. One of the most important reasons
is traumatic delivery. 10 % of women develop anal incontinence after first delivery. This
incidence is higher after second vaginal delivery, particularly if the first delivery caused
break in the anal sphincter. One possibility to avoid anal incontinence is the caesarean
section.
So, do the investigators have to recommend caesarean section for second delivery if the
first was traumatic? But caesarean section had a morbidity. Actually, the choice between the
delivery modalities is very subjective. It seems to be very useful to compare, in randomized
controlled study, global morbidity of caesarean section and vaginal delivery for second
delivery if the first had to be traumatic after forceps with anal sphincter rupture
diagnosed with anal endosonography. In start of study, all women were included, for
randomisation ("section cesarean prophylactic" versus "vaginal delivery") if an anal
sphincter rupture is diagnosed with anal endosonography before second delivery. . Currently,
in case of refusal randomisation, women are proposed to participate to the ancillary study
(cohort study).
The primary endpoint is comparison of median incontinence score of VAISEY in the two arms
after 6 months. The secondary endpoints are urinary incontinence, quality of life and global
morbidity between the two arms after second delivery. The investigators estimated, needing
123 women in each arm.
Hospital investigators are: BICHAT Claude Bernard (Pr LUTON), Armand Trousseau (Pr BENIFLA),
Jean VERDIER (Pr CARBILLON), BEAUJON (Pr LUTON), Louis MOURIER (Pr MANDELBROT), Versailles
(Dr PANEL). Inclusion will be for 6 years and 9 months. Women will be included during the
last trimester and evaluation will be perform on 8 weeks, 6 and 12 month after delivery.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03825575 -
Sacral Neuromodulation as Treatment for Fecal Incontinence
|
N/A | |
| Completed |
NCT00605826 -
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
|
N/A | |
| Withdrawn |
NCT02208258 -
Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.
|
N/A | |
| Completed |
NCT01939821 -
A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes
|
N/A | |
| Completed |
NCT01957969 -
French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence
|
N/A | |
| Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
| Recruiting |
NCT00530933 -
Tibial Nerve Stimulation for Faecal Incontinence
|
N/A | |
| Completed |
NCT00565136 -
Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00522691 -
Efficacy of Sacral Nerve Stimulation Before Definitive Implantation
|
N/A | |
| Completed |
NCT00677508 -
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
|
||
| Completed |
NCT05032534 -
Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence
|
N/A | |
| Completed |
NCT05058326 -
Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
|
||
| Completed |
NCT03746834 -
NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation
|
Phase 4 | |
| Completed |
NCT00124904 -
Biofeedback for Fecal Incontinence
|
N/A | |
| Completed |
NCT03028636 -
LIBERATE - PRO: Eclipseâ„¢ System Registry
|
||
| Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 | |
| Completed |
NCT05621629 -
Management of FI After Surgery of ARM
|
||
| Withdrawn |
NCT04138602 -
BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence
|
N/A | |
| Completed |
NCT04478799 -
Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience
|
N/A | |
| Completed |
NCT03252951 -
Physical Therapy for Anal Incontinence
|
N/A |